Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2001 Mar 1;354(Pt 2):465–472. doi: 10.1042/0264-6021:3540465

Identification of an extracellular segment of the oxytocin receptor providing agonist-specific binding epitopes.

S R Hawtin 1, H C Howard 1, M Wheatley 1
PMCID: PMC1221676  PMID: 11171127

Abstract

The effects of the peptide hormone oxytocin are mediated by oxytocin receptors (OTRs) expressed by the target tissue. The OTR is a member of the large family of G-protein-coupled receptors. Defining differences between the interaction of agonists and antagonists with the OTR at the molecular level is of fundamental importance, and is addressed in this study. Using truncated and chimaeric receptor constructs, we establish that a small 12-residue segment in the distal portion of the N-terminus of the human OTR provides important epitopes which are required for agonist binding. In contrast, this segment does not contribute to the binding site for antagonists, whether peptide or non-peptide. It does, however, have a role in agonist-induced OTR signalling. Oxytocin is also an agonist at the vasopressin V(1a) receptor (V(1a)R). A chimaeric receptor (V(1a)R(N)-OTR) was engineered in which the N-terminus of the OTR was substituted by the corresponding, but unrelated, sequence from the N-terminus of the V(1a)R. We show that the V(1a)R N-terminus present in V(1a)R(N)-OTR fully restored both agonist binding and intracellular signalling to a dysfunctional truncated OTR construct. The N-terminal segment does not, however, contribute to receptor-selective agonism between the OTR and the V(1a)R. Our data establish a key role for the distal N-terminus of the OTR in providing agonist-specific binding epitopes.

Full Text

The Full Text of this article is available as a PDF (179.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cheng Y., Prusoff W. H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973 Dec 1;22(23):3099–3108. doi: 10.1016/0006-2952(73)90196-2. [DOI] [PubMed] [Google Scholar]
  2. Dawood M. Y. Novel approach to oxytocin induction-augmentation of labor. Application of oxytocin physiology during pregnancy. Adv Exp Med Biol. 1995;395:585–594. [PubMed] [Google Scholar]
  3. Fong T. M., Yu H., Huang R. R., Strader C. D. The extracellular domain of the neurokinin-1 receptor is required for high-affinity binding of peptides. Biochemistry. 1992 Dec 1;31(47):11806–11811. doi: 10.1021/bi00162a019. [DOI] [PubMed] [Google Scholar]
  4. Fuchs A. R., Fuchs F., Husslein P., Soloff M. S. Oxytocin receptors in the human uterus during pregnancy and parturition. Am J Obstet Gynecol. 1984 Nov 15;150(6):734–741. doi: 10.1016/0002-9378(84)90677-x. [DOI] [PubMed] [Google Scholar]
  5. Goodwin T. M., Valenzuela G. J., Silver H., Creasy G. Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group. Obstet Gynecol. 1996 Sep;88(3):331–336. doi: 10.1016/0029-7844(96)00200-1. [DOI] [PubMed] [Google Scholar]
  6. Hjorth S. A., Schambye H. T., Greenlee W. J., Schwartz T. W. Identification of peptide binding residues in the extracellular domains of the AT1 receptor. J Biol Chem. 1994 Dec 9;269(49):30953–30959. [PubMed] [Google Scholar]
  7. Howl J., Ismail T., Strain A. J., Kirk C. J., Anderson D., Wheatley M. Characterization of the human liver vasopressin receptor. Profound differences between human and rat vasopressin-receptor-mediated responses suggest only a minor role for vasopressin in regulating human hepatic function. Biochem J. 1991 May 15;276(Pt 1):189–195. doi: 10.1042/bj2760189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Howl J., Langel U., Hawtin S. R., Valkna A., Yarwood N. J., Saar K., Wheatley M. Chimeric strategies for the rational design of bioactive analogs of small peptide hormones. FASEB J. 1997 Jun;11(7):582–590. doi: 10.1096/fasebj.11.7.9212082. [DOI] [PubMed] [Google Scholar]
  9. Howl J., Rudge S. A., Lavis R. A., Davies A. R., Parslow R. A., Hughes P. J., Kirk C. J., Michell R. H., Wheatley M. Rat testicular myoid cells express vasopressin receptors: receptor structure, signal transduction, and developmental regulation. Endocrinology. 1995 May;136(5):2206–2213. doi: 10.1210/endo.136.5.7536665. [DOI] [PubMed] [Google Scholar]
  10. Howl J., Wang X., Kirk C. J., Wheatley M. Fluorescent and biotinylated linear peptides as selective bifunctional ligands for the V1a vasopressin receptor. Eur J Biochem. 1993 Apr 15;213(2):711–719. doi: 10.1111/j.1432-1033.1993.tb17811.x. [DOI] [PubMed] [Google Scholar]
  11. Huang R. R., Vicario P. P., Strader C. D., Fong T. M. Identification of residues involved in ligand binding to the neurokinin-2 receptor. Biochemistry. 1995 Aug 8;34(31):10048–10055. doi: 10.1021/bi00031a029. [DOI] [PubMed] [Google Scholar]
  12. Kimura T., Makino Y., Bathgate R., Ivell R., Nobunaga T., Kubota Y., Kumazawa I., Saji F., Murata Y., Nishihara T. The role of N-terminal glycosylation in the human oxytocin receptor. Mol Hum Reprod. 1997 Nov;3(11):957–963. doi: 10.1093/molehr/3.11.957. [DOI] [PubMed] [Google Scholar]
  13. Kimura T., Saji F. Molecular Endocrinology of the oxytocin receptor. Endocr J. 1995 Oct;42(5):607–615. doi: 10.1507/endocrj.42.607. [DOI] [PubMed] [Google Scholar]
  14. Kimura T., Tanizawa O., Mori K., Brownstein M. J., Okayama H. Structure and expression of a human oxytocin receptor. Nature. 1992 Apr 9;356(6369):526–529. doi: 10.1038/356526a0. [DOI] [PubMed] [Google Scholar]
  15. Kozak M. Adherence to the first-AUG rule when a second AUG codon follows closely upon the first. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2662–2666. doi: 10.1073/pnas.92.7.2662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lowbridge J., Manning M., Haldar J., Sawyer W. H. Synthesis and some pharmacological properties of [4-threonine, 7-glycine]oxytocin, [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine, 7-glycine]oxytocin (hydroxy[Thr4, Gly7]oxytocin), and [7-Glycine]oxytocin, peptides with high oxytocic-antidiuretic selectivity. J Med Chem. 1977 Jan;20(1):120–123. doi: 10.1021/jm00211a025. [DOI] [PubMed] [Google Scholar]
  17. Maggi M., Fantoni G., Baldi E., Cioni A., Rossi S., Vannelli G. B., Melin P., Akerlund M., Serio M. Antagonists for the human oxytocin receptor: an in vitro study. J Reprod Fertil. 1994 Jul;101(2):345–352. doi: 10.1530/jrf.0.1010345. [DOI] [PubMed] [Google Scholar]
  18. Mouillac B., Chini B., Balestre M. N., Elands J., Trumpp-Kallmeyer S., Hoflack J., Hibert M., Jard S., Barberis C. The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions. J Biol Chem. 1995 Oct 27;270(43):25771–25777. doi: 10.1074/jbc.270.43.25771. [DOI] [PubMed] [Google Scholar]
  19. Pettibone D. J., Guidotti M., Harrell C. M., Jasper J. R., Lis E. V., O'Brien J. A., Reiss D. R., Woyden C. J., Bock M. G., Evans B. E. Progress in the development of oxytocin antagonists for use in preterm labor. Adv Exp Med Biol. 1995;395:601–612. [PubMed] [Google Scholar]
  20. Pettibone D. J., Kishel M. T., Woyden C. J., Clineschmidt B. V., Bock M. G., Freidinger R. M., Veber D. F., Williams P. D. Radioligand binding studies reveal marked species differences in the vasopressin V1 receptor of rat, rhesus and human tissues. Life Sci. 1992;50(25):1953–1958. doi: 10.1016/0024-3205(92)90524-s. [DOI] [PubMed] [Google Scholar]
  21. Postina R., Kojro E., Fahrenholz F. Separate agonist and peptide antagonist binding sites of the oxytocin receptor defined by their transfer into the V2 vasopressin receptor. J Biol Chem. 1996 Dec 6;271(49):31593–31601. doi: 10.1074/jbc.271.49.31593. [DOI] [PubMed] [Google Scholar]
  22. Sermasi E., Coote J. H. Oxytocin acts at V1 receptors to excite sympathetic preganglionic neurones in neonate rat spinal cord in vitro. Brain Res. 1994 Jun 6;647(2):323–332. doi: 10.1016/0006-8993(94)91331-5. [DOI] [PubMed] [Google Scholar]
  23. Soloff M. S., Alexandrova M., Fernstrom M. J. Oxytocin receptors: triggers for parturition and lactation? Science. 1979 Jun 22;204(4399):1313–1315. doi: 10.1126/science.221972. [DOI] [PubMed] [Google Scholar]
  24. Valenzuela G. J., Sanchez-Ramos L., Romero R., Silver H. M., Koltun W. D., Millar L., Hobbins J., Rayburn W., Shangold G., Wang J. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group. Am J Obstet Gynecol. 2000 May;182(5):1184–1190. doi: 10.1067/mob.2000.105816. [DOI] [PubMed] [Google Scholar]
  25. Wheatley M., Howl J., Yarwood N. J., Davies A. R., Parslow R. A. Preparation of a membrane fraction for receptor studies and solubilization of receptor proteins with retention of biological activity. Methods Mol Biol. 1997;73:305–322. doi: 10.1385/0-89603-399-6:305. [DOI] [PubMed] [Google Scholar]
  26. Wigler M., Silverstein S., Lee L. S., Pellicer A., Cheng Y. c., Axel R. Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells. Cell. 1977 May;11(1):223–232. doi: 10.1016/0092-8674(77)90333-6. [DOI] [PubMed] [Google Scholar]
  27. Williams P. D., Bock M. G., Evans B. E., Freidinger R. M., Pettibone D. J. Progress in the development of oxytocin antagonists for use in preterm labor. Adv Exp Med Biol. 1998;449:473–479. doi: 10.1007/978-1-4615-4871-3_61. [DOI] [PubMed] [Google Scholar]
  28. Williams P. D., Clineschmidt B. V., Erb J. M., Freidinger R. M., Guidotti M. T., Lis E. V., Pawluczyk J. M., Pettibone D. J., Reiss D. R., Veber D. F. 1-(1-[4-[(N-acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4- yl)-4H-3,1-benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist. J Med Chem. 1995 Nov 10;38(23):4634–4636. doi: 10.1021/jm00023a002. [DOI] [PubMed] [Google Scholar]
  29. Xue J. C., Chen C., Zhu J., Kunapuli S., DeRiel J. K., Yu L., Liu-Chen L. Y. Differential binding domains of peptide and non-peptide ligands in the cloned rat kappa opioid receptor. J Biol Chem. 1994 Dec 2;269(48):30195–30199. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES